ArticleNature medicine2026

Glucagon-like peptide-1 receptor agonists for major cardiovascular and kidney outcomes in type 1 diabetes.

Yunwen Xu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.